Hepatitis C Information Central


Discover the latest news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information

News, Updates and Commentary

Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

77 more hepatitis cases may trace to clinic, officials say
LAS VEGAS --Seventy-seven more people who were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said. Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist

77 more hepatitis cases may trace to clinic
LAS VEGAS (AP) - Health officials in Las Vegas say 77 more people who were treated at an outpatient clinic have been diagnosed with hepatitis C. Authorities can't say for sure how the 77 people were infected. Officials say they know each was treated from


UPDATES AND COMMENTARY RSS Feed

Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...

Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...

Hepatitis C Complications Helped by Maintenance Interferon
A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C....

Targeted Cryoablation Shows Promise In Liver Cancer Treatment

IRVINE, CA -- Aug. 6, 1998 -- Study data published in the journal Cancer shows that Endocare, Inc.’s targeted cryoablation technology designed to treat liver cancer shows promise in treating the disease and may be able to prolong patient survival.

"Utilising Endocare's unique freezing and temperature monitoring technology, we are able to apply extremely cold temperatures to targeted cancerous tissue until it has been broken down and no longer exists," said Wilson Wong, M.D., a radiologist based at Southern California's Alhambra Hospital and one of the study’s authors. "We are very encouraged by early data. Results show that targeted cryoablation can be effective in patients where surgical resection is not an effective option.

"In the treatment of liver cancer, targeted ablation enables us to rid the liver of more cancerous tissue while the technology's precise targeting element allows us to spare the sections of the liver that are not cancerous."

Because it is one of the most malignant forms of cancer, hepatocellular carcinoma (liver cancer) is a disease that has traditionally been very difficult to treat. The reported incidence is three per 100,000 per year in the United States, rising to 30 per 100,000 internationally. Patients suffering from the disease generally have a poor prognosis. Endocare's targeted cryoablation equipment is particularly groundbreaking because cancerous tumours of the liver usually cannot be removed surgically.

The targeted cryoablation devices used in treating liver cancer are the latest in a growing series of temperature-based technologies developed by Endocare, including similar targeted cryoablation devices that have exhibited success in treating prostate cancer.

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 12 May 2008